Please Wait
Applying Filters...
menu
    • menu
    AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

    Stock Recap
    #PipelineProspector

    Menu

    Litocit

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    30/12/2024 Dr. Paul Lohmann GmbH KG
    Germany
    		 Dr. Paul Lohmann GmbH & Co. KGaA 221MF10109 Potassium citrate 2009-06-02 2009-06-02 Hauptstrasse 2 D-31860 Emmerthal Germany
    30/12/2024 Komatsuya
    Japan
    		 Komatsuya Co., Ltd. 219MF10180 Japanese Pharmacopoeia Non-Drug Standard Potassium Citr... 2007-06-01 2007-06-01 Matsuura Sakaisuji Honmachi Building, 1-9-28 Kyutarocho, Chuo-ku, Osaka City, Osaka Prefecture